Moderna Inc (NAS:MRNA)
$ 128.32 2.65 (2.11%) Market Cap: 49.18 Bil Enterprise Value: 40.89 Bil PE Ratio: 0 PB Ratio: 3.83 GF Score: 68/100

Moderna Inc at Oppenheimer Healthcare Conference (Virtual) Transcript

Mar 16, 2021 / 05:50PM GMT
Release Date Price: $156.02 (+8.60%)
Hartaj Singh
Oppenheimer & Co. Inc., Research Division - Research Analyst

Great. Thank you, John. Hi, everybody. Thanks for joining us back. I hope you had a good lunch or a beer or a nice little break. We have today Tal Zaks, the Chief Medical Officer of Moderna, here with us, joining us in our fireside chat with Moderna. I was just reminding Tal, that he and I met in person for the first time 2 years ago at the Oppenheimer Healthcare Conference. And I just had a really, really great chat with him. And in fact, I can remember pretty much every time whenever we interacted because I've learned a lot from him and his team and what Moderna has done. It has been a historic year since -- over the last year and since last year at our virtual health care conference. So Tal, thank you so very much for joining us.

Tal Zaks;Hartaj Singh
Moderna, Inc. - Chief Medical Officer;Oppenheimer & Co. Inc.,

It's a real pleasure to be here again. Good to see you. I wish this were in person, but next time, hopefully, it will be in person.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot